Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 2002;100:864-868
© 2002 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Broder, M. S.
Right arrow Articles by Erberich, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Broder, M. S.
Right arrow Articles by Erberich, H.

ORIGINAL RESEARCH

Comparison of Long-Term Outcomes of Myomectomy and Uterine Artery Embolization

Michael S. Broder, MD, Scott Goodwin, MD, Gary Chen, MD, Linda J. Tang, MD, Mary M. Costantino, MD, Michael H. Nguyen, MD, Tugce N. Yegul, MD and Heike Erberich, MD

From the Departments of Obstetrics & Gynecology and Radiology, UCLA School of Medicine, Los Angeles, California; Department of Radiology, Wayne State University, Detroit, Michigan; Barnes-Jewish Hospital, St. Louis, Missouri; Cedars Sinai Medical Center, Los Angeles, California; Stanford University, Palo Alto, California; Santa Clara Valley Medical Center, San Jose, California; and University of Koln, Koln, Germany.

Address reprint requests to: Michael S. Broder, MD, UCLA School of Medicine, Department of Obstetrics and Gynecology, 10833 Le Conte Avenue, Box 951740, Los Angeles, CA 90095-1740; E-mail: mbroder{at}ucla.edu.

OBJECTIVE: To compare long-term outcomes of uterine artery embolization and abdominal myomectomy in patients with symptomatic uterine myomas.

METHODS: At a single institution in an 18-month time, 59 patients had bilateral uterine artery embolization and 38 patients had abdominal myomectomy to treat symptomatic uterine myomas. We reviewed medical records and surveyed patients 3 or more years after their procedures to assess how many needed further surgical procedures in the intervening years, to what extent symptoms remained improved, and how satisfied the patients were with the long term results of the index procedure.

RESULTS: Follow-up was available on 51 embolization and 30 myomectomy patients and ranged from 37 to 59 months. Patients who had embolization were older (44 versus 38 years, P < .001) and more likely to have had previous surgical procedures (P < .001) than those who had myomectomy. Taking into account the variable follow-up period, embolization patients were more likely to have had further invasive treatment for myomas (29% versus 3%) (P = .004). Among women not needing further surgery, overall symptoms improved in 92% (33/36) of embolization and 90% (26/29) of myomectomy patients (P = .78). Ninety-four percent (34/36) of embolization patients and 79% (23/29) of myomectomy patients were at least somewhat satisfied with their choice of procedure (P = .06).

CONCLUSION: Women who had embolization were more likely than those who had myomectomy to need further invasive treatment (surgery or repeat embolization) in the 3–5 years after the index procedure. Among women who did not need such treatment, satisfaction and relief of symptoms were similar. Large, randomized trials are needed to more accurately compare these two procedures.




This article has been cited by other articles:


Home page
 Hum Reprod UpdateHome page
G. Tropeano, S. Amoroso, and G. Scambia
Non-surgical management of uterine fibroids
Hum. Reprod. Update, May 1, 2008; 14(3): 259 - 274.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
C. Scheurig, A. Gauruder-Burmester, C. Kluner, R. Kurzeja, A. Lembcke, E. Zimmermann, B. Hamm, and T. Kroencke
Uterine artery embolization for symptomatic fibroids: short-term versus mid-term changes in disease-specific symptoms, quality of life and magnetic resonance imaging results
Hum. Reprod., December 1, 2006; 21(12): 3270 - 3277.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
H. T. Sharp
Assessment of new technology in the treatment of idiopathic menorrhagia and uterine leiomyomata.
Obstet. Gynecol., October 1, 2006; 108(4): 990 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
J. B. Spies
Adding to our understanding of uterine fibroid embolization.
Am. J. Roentgenol., March 1, 2006; 186(3): 846 - 847.
[Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
T. Katsumori, T. Kasahara, and K. Akazawa
Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids.
Am. J. Roentgenol., March 1, 2006; 186(3): 848 - 854.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
J. B. Spies, J. Bruno, F. Czeyda-Pommersheim, S. T. Magee, S. A. Ascher, and R. C. Jha
Long-Term Outcome of Uterine Artery Embolization of Leiomyomata
Obstet. Gynecol., November 1, 2005; 106(5): 933 - 939.
[Abstract] [Full Text] [PDF]

Home page
 JWatch Women's HealthHome page
Is Embolization As Effective As Myomectomy for Treating Uterine Myomas?
Journal Watch Women's Health, December 4, 2002; 2002(1204): 4 - 4.
[Full Text]

Home page
 Obstet GynecolHome page
E. R. Myers
Uterine Artery Embolization: What More Do We Need to Know?
Obstet. Gynecol., November 1, 2002; 100(5): 847 - 848.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American College of Obstetricians and Gynecologists.